FDA Inspection 1045598 — Tomita Pharmaceutical Co., Ltd.

Tomita Pharmaceutical Co., Ltd. — FEI 3002808375

The FDA completed an inspection of Tomita Pharmaceutical Co., Ltd. on Mar 9, 2018 in Naruto. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 9, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Naruto (Japan)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
125121 CFR 211.42(c)(1)Incoming material area
188521 CFR 211.165(b)Microbiological testing
356521 CFR 211.58Buildings not maintained in good state of repair

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.